Mesothelioma Treatment
Mesothelioma Cancer
- Causes of Mesothelioma
- Mesothelioma Symptoms
- Mesothelioma Diagnosis
- Mesothelioma Stages
- Mesothelioma Treatment
- Innovative Mesothelioma Treatments
- Managing Mesothelioma Pain
- Nutrition Information for Mesothelioma Patients
- Specialized Mesothelioma Care
- Mesothelioma Risks
- Mesothelioma Support Groups
- Find a Mesothelioma Attorney
- Mesothelioma News
Mesothelioma Directory
Flavopiridol in Treating Patients With Metastatic or Unresectable Refractory Solid Tumors or Hematologic Malignancies
Get Help Today
Looking for help or additional information? Contact us today.| Conditions: | Cancer |
| Start Date: | October 1, 2003 |
| Phase: | Phase I |
| Status: | Suspended |
| NCT ID: | NCT00070239 |
| Study Type: | Interventional |
| Intervention: | Drug: alvocidib |
| Study Design: | Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Dana-Farber Cancer Institute|National Cancer Institute (NCI) |
| Ages: | Adult|Senior |
| Enrollment: | 80 |
| Funded By: | Other|NIH |
| First Received: | October 3, 2003 |
| End Date: | |
| Last Updated: | March 13, 2010 |
| Last Verified: | June 1, 2008 |